GENE ONLINE|News &
Opinion
Blog

COVID-19 Treatment
EMA Begins Reviewing Cancer Medicine for COVID-19 Without Manufacturer’s Application
2022-07-28
Monoclonal Antibody Discovered to Potentially Act Against All Coronaviruses
2022-07-25
Brii Biosciences Begins Marketing COVID-19 Antibody Cocktail Therapy in China
2022-07-07
Genetics May Be a Factor in Varying COVID-19 Severity
2022-05-20
FDA Rejects Emergency Use Authorization for Common and Inexpensive Antidepressant COVID-19 Treatment
2022-05-20
Pfizer to Address COVID-19 Reinfection After Paxlovid Treatment
2022-05-19
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05
Can Vaccination Provide Protection Against Highly Infectious BA.2 Omicron Variant?
2022-03-23
Shionogi’s COVID-19 Oral Drug and Nasal Vaccine Makes Headway in Trials
2021-09-29
Purine Repressing Probiotic Might Halt COVID-19, says Korean Researchers
2020-03-21
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top